MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), a prominent player in the medical device industry in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its third-generation transcatheter aortic valve implantation (TAVI) product, VitaFlow Liberty Flex. This marks a significant advancement in the field of cardiac valve replacement technologies.
VitaFlow Liberty Flex: Enhancing TAVI Procedure Precision
VitaFlow Liberty Flex is an upgraded version of the second-generation TAVI product, VitaFlow Liberty, and introduces a new 3D spatial bending function to the market. This innovative feature, along with its unique inner tube bending technology, maintains the valve’s coaxiality during the release process. This enhancement leads to a more stable and precise implantation, ensuring a smoother and safer passage through the aortic arch and valve.
Advantages and Safety Features of VitaFlow Liberty Flex
One of the standout features of VitaFlow Liberty Flex is its ability to align valve release boundaries, which protects coronary pathways and reserves space for potential future coronary interventions. This design consideration is particularly important for patients who may require additional cardiac procedures in the future, showcasing the product’s forward-thinking approach to patient care.-Fineline Info & Tech
Leave a Reply